91黑料 experts frequently author or contribute to industry trade press.
Filter media
Filter media articles by either clicking within the ‘Category’ drop-down list, or begin typing which will automatically match to the nearest available category. Note - not all categories will display results if selecting a particular year.
-
The COVID-19 pandemic has challenged the traditional onsite congress engagement experience and forced pharma to rethink face to face events.
-
Going through changes
91黑料's Angela Brown considers what manufacturers can learn from medical device regulation (MDR) and the effect it will have on the in vitro diagnostic landscape (IVD)
-
Scientific Affairs Manager Candice Willey provides commentary on the difficulties of using CTCs in diagnostic testing despite their promise, the emergence of new CTC technologies to improve tumor sample accessibility, and the benefits of integrating CTC information into clinical trial decisions.
-
BioPharm International speaks with 91黑料's Robert Kernstock about the need for bioanalytical testing programs and regulatory strategies for potential new biologics.
-
A thought leadership article authored by Jack Martin, Mary Jane Geiger and Deirdre Albertson which focuses on navigating cardiovascular clinical trials during COVID-19 by adopting patient-centric technologies to keep patients safe and studies on track. .
-
A article featuring about the development of a vaccine for COVID-19.
-
As specialty therapies move toward long-term maintenance use and as treatment times grow longer, payers are scrutinising the economic value more closely. 91黑料 experts discuss how clinical development can better satisfy the evidence needs of HTA bodies and payers.
-
Dr. Kristen Buck joins 91黑料 as its new chief medical officer.
-
91黑料's Cindy Dukes considers the best practices for developing a vaccine and treatments for COVID-19.
-
Fierce Biotech reports on 91黑料's appointment of Dr. Kristen Buck as its new chief medical officer.
